Annual CFI
-$18.20 M
-$91.38 M-124.87%
31 December 2021
Summary:
Aerie Pharmaceuticals annual cash flow from investing activities is currently -$18.20 million, with the most recent change of -$91.38 million (-124.87%) on 31 December 2021. During the last 3 years, it has fallen by -$91.38 million (-124.87%).AERI Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$25.86 M
+$29.80 M+757.78%
30 September 2022
Summary:
Aerie Pharmaceuticals quarterly cash flow from investing activities is currently $25.86 million, with the most recent change of +$29.80 million (+757.78%) on 30 September 2022.AERI Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$18.30 M
+$24.73 M+57.47%
30 September 2022
Summary:
Aerie Pharmaceuticals TTM cash flow from investing activities is currently -$18.30 million, with the most recent change of +$24.73 million (+57.47%) on 30 September 2022.AERI TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AERI Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -124.9% | +2186.8% | +13.8% |
| 5 y5 years | -187.6% | +126.4% | +82.8% |
AERI Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -124.9% | -53.1% | -125.0% |
Aerie Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $25.86 M(-757.8%) | -$18.30 M(-57.5%) |
| June 2022 | - | -$3.93 M(-90.7%) | -$43.04 M(-31.4%) |
| Mar 2022 | - | -$42.30 M(-2150.4%) | -$62.78 M(+244.9%) |
| Dec 2021 | -$18.20 M(-124.9%) | $2.06 M(+82.4%) | -$18.20 M(-14.3%) |
| Sept 2021 | - | $1.13 M(-104.8%) | -$21.24 M(-0.9%) |
| June 2021 | - | -$23.68 M(-1138.4%) | -$21.43 M(-151.0%) |
| Mar 2021 | - | $2.28 M(-333.8%) | $41.98 M(-42.6%) |
| Dec 2020 | $73.18 M(-139.9%) | -$975.00 K(-203.5%) | $73.18 M(-1969.7%) |
| Sept 2020 | - | $942.00 K(-97.6%) | -$3.91 M(-96.2%) |
| June 2020 | - | $39.73 M(+18.7%) | -$102.92 M(-28.9%) |
| Mar 2020 | - | $33.48 M(-142.9%) | -$144.82 M(-21.0%) |
| Dec 2019 | -$183.25 M(-981.5%) | -$78.07 M(-20.4%) | -$183.25 M(+72.7%) |
| Sept 2019 | - | -$98.06 M(+4400.3%) | -$106.09 M(<-9900.0%) |
| June 2019 | - | -$2.18 M(-55.9%) | $71.00 K(-99.9%) |
| Mar 2019 | - | -$4.94 M(+443.3%) | $57.40 M(+176.1%) |
| Dec 2018 | $20.79 M(-148.6%) | -$909.00 K(-111.2%) | $20.79 M(-46.0%) |
| Sept 2018 | - | $8.10 M(-85.3%) | $38.48 M(+1177.3%) |
| June 2018 | - | $55.15 M(-232.7%) | $3.01 M(-105.9%) |
| Mar 2018 | - | -$41.55 M(-347.5%) | -$50.75 M(+18.6%) |
| Dec 2017 | -$42.81 M | $16.79 M(-161.3%) | -$42.81 M(-22.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | -$27.37 M(-2076.5%) | -$55.51 M(+188.4%) |
| June 2017 | - | $1.39 M(-104.1%) | -$19.25 M(+7.3%) |
| Mar 2017 | - | -$33.60 M(-922.6%) | -$17.94 M(-199.1%) |
| Dec 2016 | $18.10 M(+92.9%) | $4.08 M(-54.0%) | $18.10 M(+101.1%) |
| Sept 2016 | - | $8.89 M(+230.1%) | $9.00 M(+73.1%) |
| June 2016 | - | $2.69 M(+10.5%) | $5.20 M(-9.0%) |
| Mar 2016 | - | $2.44 M(-148.6%) | $5.72 M(-39.1%) |
| Dec 2015 | $9.38 M(-112.8%) | -$5.01 M(-198.6%) | $9.38 M(-125.8%) |
| Sept 2015 | - | $5.09 M(+58.5%) | -$36.34 M(+3.6%) |
| June 2015 | - | $3.21 M(-47.4%) | -$35.08 M(-7.3%) |
| Mar 2015 | - | $6.10 M(-112.0%) | -$37.84 M(-48.4%) |
| Dec 2014 | -$73.32 M(>+9900.0%) | -$50.74 M(-899.4%) | -$73.32 M(+224.2%) |
| Sept 2014 | - | $6.35 M(+1316.7%) | -$22.61 M(-21.9%) |
| June 2014 | - | $448.00 K(-101.5%) | -$28.97 M(-1.6%) |
| Mar 2014 | - | -$29.37 M(>+9900.0%) | -$29.43 M(>+9900.0%) |
| Dec 2013 | -$63.00 K(+23.5%) | -$35.00 K(+218.2%) | -$63.00 K(+125.0%) |
| Sept 2013 | - | -$11.00 K(0.0%) | -$28.00 K(+64.7%) |
| June 2013 | - | -$11.00 K(+83.3%) | -$17.00 K(+183.3%) |
| Mar 2013 | - | -$6000.00 | -$6000.00 |
| Dec 2012 | -$51.00 K(+4.1%) | - | - |
| Dec 2011 | -$49.00 K | - | - |
FAQ
- What is Aerie Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Aerie Pharmaceuticals?
- What is Aerie Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Aerie Pharmaceuticals?
- What is Aerie Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Aerie Pharmaceuticals?
What is Aerie Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of AERI is -$18.20 M
What is the all time high annual CFI for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high annual cash flow from investing activities is $73.18 M
What is Aerie Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of AERI is $25.86 M
What is the all time high quarterly CFI for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high quarterly cash flow from investing activities is $55.15 M
What is Aerie Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of AERI is -$18.30 M
What is the all time high TTM CFI for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high TTM cash flow from investing activities is $73.18 M